We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRL icon
7226
Sterling Infrastructure
STRL
$17B
$877K ﹤0.01%
+39,965
New +$960K
BSM icon
7227
Black Stone Minerals
BSM
$3.1B
$876K ﹤0.01%
63,991
-88,951
-58% -$1.35M
MNDY icon
7228
monday.com
MNDY
$3.72B
$876K ﹤0.01%
8,488
-77,689
-90% -$9.44M
RVAC
7229
CALL
DELISTED
Riverview Acquisition Corp. Class A Common Stock
RVAC
$876K ﹤0.01%
+88,000
New +$873K
ENV
7230
PUT
DELISTED
ENVESTNET, INC.
ENV
$876K ﹤0.01%
16,600
+9,100
+121% +$622K
GHI icon
7231
CALL
Greystone Housing Impact Investors LP
GHI
$156M
$875K ﹤0.01%
+49,640
New +$856K
MYOV
7232
PUT
DELISTED
Myovant Sciences Ltd.
MYOV
$874K ﹤0.01%
70,300
-23,600
-25% -$260K
ASB icon
7233
CALL
Associated Banc-Corp
ASB
$5.98B
$873K ﹤0.01%
47,800
+2,000
+4% +$40.5K
DNA icon
7234
PUT
Ginkgo Bioworks
DNA
$440M
$872K ﹤0.01%
9,163
+2,653
+41% +$324K
AMRS
7235
PUT
DELISTED
Amyris Inc.
AMRS
$872K ﹤0.01%
471,200
+181,600
+63% +$535K
AVPT icon
7236
CALL
AvePoint
AVPT
$2.82B
$871K ﹤0.01%
200,700
+26,100
+15% +$133K
AZN icon
7237
AstraZeneca
AZN
$248B
$871K ﹤0.01%
6,592
-2,146
-25% -$282K
CRTO icon
7238
PUT
Criteo S.A.
CRTO
$876M
$871K ﹤0.01%
35,700
-59,000
-62% -$1.5M
GAN
7239
DELISTED
GAN Ltd
GAN
$871K ﹤0.01%
294,451
-265,524
-47% -$983K
FBGX
7240
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
$871K ﹤0.01%
2,192
+324
+17% +$167K
LKFT
7241
PUT
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.83B
$870K ﹤0.01%
15,600
-6,000
-28% -$356K
TAC icon
7242
CALL
TransAlta
TAC
$3.94B
$870K ﹤0.01%
+76,300
New +$841K
USL icon
7243
CALL
United States 12 Month Oil Fund,
USL
$47M
$870K ﹤0.01%
22,000
-5,800
-21% -$234K
NVTA
7244
PUT
DELISTED
Invitae Corporation
NVTA
$869K ﹤0.01%
356,200
-1,900
-0.5% -$8.4K
ZUO
7245
PUT
DELISTED
Zuora, Inc.
ZUO
$868K ﹤0.01%
97,000
+27,300
+39% +$303K
SPXB
7246
DELISTED
ProShares S&P 500 Bond ETF
SPXB
$868K ﹤0.01%
11,359
-2,332
-17% -$182K
PFHD
7247
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$868K ﹤0.01%
43,316
+19,281
+80% +$424K
APOG icon
7248
PUT
Apogee Enterprises
APOG
$861M
$867K ﹤0.01%
22,100
+12,900
+140% +$552K
GPK icon
7249
CALL
Graphic Packaging
GPK
$3.25B
$867K ﹤0.01%
42,300
-17,800
-30% -$376K
IBTL icon
7250
iShares iBonds Dec 2031 Term Treasury ETF
IBTL
$677M
$867K ﹤0.01%
+39,658
New +$869K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.